1. Home
  2. BCAB vs ZCMD Comparison

BCAB vs ZCMD Comparison

Compare BCAB & ZCMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCAB
  • ZCMD
  • Stock Information
  • Founded
  • BCAB 2007
  • ZCMD 2012
  • Country
  • BCAB United States
  • ZCMD China
  • Employees
  • BCAB N/A
  • ZCMD N/A
  • Industry
  • BCAB Medicinal Chemicals and Botanical Products
  • ZCMD Other Consumer Services
  • Sector
  • BCAB Health Care
  • ZCMD Real Estate
  • Exchange
  • BCAB Nasdaq
  • ZCMD Nasdaq
  • Market Cap
  • BCAB 27.0M
  • ZCMD 30.3M
  • IPO Year
  • BCAB 2020
  • ZCMD 2020
  • Fundamental
  • Price
  • BCAB $0.32
  • ZCMD $1.19
  • Analyst Decision
  • BCAB Buy
  • ZCMD
  • Analyst Count
  • BCAB 2
  • ZCMD 0
  • Target Price
  • BCAB $1.00
  • ZCMD N/A
  • AVG Volume (30 Days)
  • BCAB 534.1K
  • ZCMD 3.9K
  • Earning Date
  • BCAB 05-13-2025
  • ZCMD 01-01-0001
  • Dividend Yield
  • BCAB N/A
  • ZCMD N/A
  • EPS Growth
  • BCAB N/A
  • ZCMD N/A
  • EPS
  • BCAB N/A
  • ZCMD N/A
  • Revenue
  • BCAB $11,000,000.00
  • ZCMD $17,406,104.00
  • Revenue This Year
  • BCAB N/A
  • ZCMD N/A
  • Revenue Next Year
  • BCAB N/A
  • ZCMD N/A
  • P/E Ratio
  • BCAB N/A
  • ZCMD N/A
  • Revenue Growth
  • BCAB N/A
  • ZCMD 1.01
  • 52 Week Low
  • BCAB $0.24
  • ZCMD $1.00
  • 52 Week High
  • BCAB $3.53
  • ZCMD $2.97
  • Technical
  • Relative Strength Index (RSI)
  • BCAB 47.19
  • ZCMD 39.96
  • Support Level
  • BCAB $0.26
  • ZCMD $1.20
  • Resistance Level
  • BCAB $0.34
  • ZCMD $1.46
  • Average True Range (ATR)
  • BCAB 0.04
  • ZCMD 0.07
  • MACD
  • BCAB 0.00
  • ZCMD -0.01
  • Stochastic Oscillator
  • BCAB 58.00
  • ZCMD 0.00

About BCAB BioAtla Inc.

BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.

About ZCMD Zhongchao Inc.

ZHONGCHAO Inc is a Cayman Islands-based provider of healthcare information, education, and training services. It provides services to healthcare professionals and the public in China. It offers online and onsite health information services, healthcare education programs, and healthcare training products, consisting of clinical practice training, open classes of popular medical topics, interactive case studies, academic conferences and workshops, continuing education courses, and articles and short videos with educational healthcare content.

Share on Social Networks: